๐Ÿฝ๏ธ
Dysphagia โ€” New Presentation Oropharyngeal vs oesophageal swallowing difficulty โ€” cancer exclusion and functional management
Progress 0 / 9

โšก Snapshot. The whole pathway on one page: act now, triage, classify, treat today and safety-net. The Steps tab holds the detail.

Open full screen โ†—
1
Safety

Red Flags โ€” Dysphagia Is an Alarm Symptom Requiring Urgent Assessment

Any unexplained dysphagia in an adult should be referred using the suspected cancer pathway for oesophageal/gastric cancer, according to the local pathway (NICE NG12 (updated April 2026), recs 1.2.1 and 1.2.7). Do not delay referral while trialling a PPI. Dysphagia is an alarm symptom requiring urgent assessment because malignancy and other significant structural disease must be excluded. Clearly neurological oropharyngeal dysphagia may instead need the acute stroke pathway, SALT, neurology or the ENT/head and neck cancer pathway, depending on the presentation.
Progressive dysphagia Solids first โ†’ then liquids (mechanical obstruction โ€” oesophageal cancer, stricture) โ†’ suspected cancer pathway referral. Any age, any duration.
Weight loss + dysphagia Oesophageal or gastric cancer โ†’ suspected cancer pathway referral. NICE NG12 (updated April 2026): dysphagia alone is a suspected cancer pathway referral at any age; weight loss adds urgency but is not needed.
Neck mass + dysphagia Hypopharyngeal cancer, thyroid mass, cervical lymphadenopathy โ†’ head and neck suspected cancer pathway referral
Hoarseness + dysphagia Recurrent laryngeal nerve involvement โ€” posterior mediastinal mass, oesophageal/lung cancer โ†’ same-day or suspected cancer pathway referral depending on tempo
Haematemesis or melaena Bleeding from oesophageal tumour, varices, peptic ulcer โ†’ 999 if active haematemesis, haemodynamic instability or known varices; otherwise same-day hospital
Acute onset + drooling + no passage Suspected complete oesophageal obstruction โ€” unable to swallow saliva, drooling or persistent regurgitation โ€” requires immediate transfer to hospital for urgent endoscopic management. Use 999 if there is airway compromise, respiratory distress, severe chest pain, suspected perforation or clinical instability. Do not attempt blind removal or force oral fluids.
Neurological symptoms + dysphagia New stroke (oropharyngeal dysphagia), motor neurone disease, Parkinson's, myasthenia โ†’ aspiration pneumonia risk โ†’ suspected acute stroke: 999 via the local stroke pathway, nil by mouth until an appropriate swallow screen, no oral medication or fluids unless specifically directed (NICE NG128); otherwise urgent neurology / SALT
Aspiration-safety red flags Wet/gurgling voice, coughing or choking during meals, recurrent lower respiratory infections, unexplained fever, reduced oxygen saturation, inability to maintain oral hydration, prolonged mealtimes or fatigue during meals, unintentional weight loss โ†’ new aspiration symptoms with respiratory compromise, hypoxia, sepsis or inability to maintain hydration require same-day hospital assessment; otherwise arrange urgent SALT and dietetic assessment
Chest pain + dysphagia Oesophageal spasm, achalasia, but also: exclude ACS + aortic dissection (referred pain) โ†’ if either is suspected, 999 (troponin is a hospital test โ€” do not request it in primary care or delay transfer for an ECG)
NICE NG12 (updated April 2026) calls for a suspected cancer pathway referral for oesophageal or stomach cancer for dysphagia at any age (the 2025 amendment replaced the earlier urgent direct-access endoscopy route) โ€” there is no age threshold below which dysphagia can be considered benign without investigation. Survival from oesophageal cancer is much better when it is diagnosed early โ€” early referral is the most impactful intervention a GP can make. Progressive dysphagia (solids โ†’ liquids) is the classic history of mechanical obstruction (tumour or benign stricture) and requires urgent assessment. Complete food bolus obstruction generally requires urgent/emergency endoscopy following the local upper-GI emergency pathway; a patient with an impaction who can manage secretions may be treated urgently rather than by ambulance.
2
Diagnose

Oropharyngeal vs Oesophageal โ€” Key Distinction

Oropharyngeal dysphagia
Difficulty initiating swallow โ€” food sticks immediately, coughing/choking at onset, nasal regurgitation, aspiration (gurgling/wet voice). Neurological or structural cause. Refer SLT urgently.
Oesophageal dysphagia
Difficulty progressing food down โ€” sticking sensation in chest/throat after swallowing, regurgitation (undigested food). Mechanical or motility cause. suspected cancer pathway referral.
Level of obstruction
Patient often localises to sternum level or throat โ€” the perceived level is often unreliable: a throat-localised sensation can arise from distal oesophageal disease.
Solids only vs both
Solids first, then liquids โ†’ progressive mechanical obstruction more likely (malignancy, stricture, Schatzki ring). Both solids and liquids from onset โ†’ motility disorder more likely (achalasia, diffuse oesophageal spasm, MND). A probability, not a diagnostic rule โ€” eosinophilic oesophagitis, rings, strictures and malignancy can present variably, and patients may describe symptoms inaccurately.
Progression
Progressive suggests mechanical obstruction โ€” urgent assessment to exclude malignancy. Intermittent / static over years โ†’ benign motility disorder more likely (achalasia, oesophageal dysmotility, functional) โ€” a probability, not a reason to skip the suspected cancer pathway referral
Associated features
Heartburn / regurgitation (GORD, peptic stricture, Barrett's oesophagus), pill ingestion (pill-induced oesophagitis โ€” bisphosphonates, doxycycline), eosinophilic oesophagitis (young atopic patients, dysphagia + food impaction)
The oropharyngeal/oesophageal distinction determines the urgency and direction of referral. Oropharyngeal dysphagia after stroke carries a high aspiration pneumonia risk โ€” follow the local stroke pathway, keep the patient nil by mouth until an appropriate swallow screen has been completed, then SALT (Speech and Language Therapy) assessment (NICE NG128). Achalasia (failure of lower oesophageal sphincter relaxation) presents classically with dysphagia for both solids and liquids from the outset, with regurgitation of undigested food, and nocturnal cough โ€” a long-standing history and younger age make it more likely, but they do not exclude cancer (which can mimic achalasia) โ€” OGD is still needed. Eosinophilic oesophagitis is an increasingly recognised cause in young atopic adults presenting with recurrent food impaction โ€” it requires endoscopy with biopsies and specialist management.
3
Diagnose

Differential Diagnosis

Oesophageal cancer
More common with age (โ‰ฅ55 with weight loss plus upper abdominal pain, reflux or dyspepsia is an NG12 trigger; dysphagia itself has no age threshold), progressive dysphagia (solids โ†’ liquids), weight loss, anaemia. Barrett's oesophagus is a risk factor. Squamous (upper) โ€” smoking/alcohol. Adenocarcinoma (lower) โ€” GORD/Barrett's.
Peptic stricture / Barrett's
Long-standing GORD โ†’ mucosal damage โ†’ stricture. Gradual onset, mainly solids, heartburn history. Endoscopy diagnostic + dilatation therapeutic.
Eosinophilic oesophagitis (EoE)
Young adults, atopy (asthma/eczema/rhinitis), recurrent food impaction (meat/bread), intermittent dysphagia. Suspected eosinophilic oesophagitis requires gastroenterology assessment, OGD with oesophageal biopsies (peak โ‰ฅ15 eosinophils/hpf, BSG 2022) and specialist-directed treatment (e.g. swallowed topical steroid, dietary exclusion). Current food impaction โ†’ same-day hospital (immediate transfer if unable to swallow saliva, as in step 1); recurrent food bolus episodes โ†’ urgent gastroenterology review.
Achalasia
Dysmotility โ€” LOS failure to relax. Dysphagia solids AND liquids, regurgitation of undigested food, nocturnal cough. Chest X-ray may show absent gastric air bubble. Oesophageal manometry diagnostic.
GORD / oesophagitis
Heartburn, regurgitation, dysphagia in context of longstanding reflux. The dysphagia itself needs a suspected cancer pathway referral at any age (NICE NG12 (updated April 2026)) โ€” do not delay it to trial a PPI; if a PPI is started for symptom control, tell the endoscopy service. Full-dose PPI for 4 or 8 weeks (4 weeks for uninvestigated dyspepsia; NICE CG184) only for reflux symptoms without dysphagia or other alarm features. Endoscopy if no response or alarm features.
Globus pharyngeus
Globus should only be considered when the patient describes a lump sensation without objective difficulty swallowing. Dysphagia, progressive symptoms, weight loss, pain, voice change or aspiration should not be attributed to globus. May coexist with reflux, laryngeal disease or anxiety. Before reassurance: confirm food and liquids pass normally, ask about weight loss, pain, voice change and aspiration, examine the neck and oropharynx, and investigate or refer if alarm features are present.
Neurological dysphagia
Parkinson's disease (oropharyngeal โ€” rigid hyoid, bradykinesia), stroke, MND (bulbar palsy โ€” combined oral + oesophageal), myasthenia gravis (fatigable, worse through meal), MS
Pharyngeal pouch (Zenker's)
Elderly, regurgitation of undigested food hours later, halitosis, gurgling, aspiration. Soft lump in neck on eating. If Zenker's is suspected, refer to ENT/upper-GI specialists. Barium swallow may be used as an initial structural study. Endoscopy should be undertaken only by an experienced team with awareness of the perforation risk.
Barrett's oesophagus (columnar metaplasia of the distal oesophagus from chronic GORD) is a precursor to oesophageal adenocarcinoma โ€” patients with Barrett's have an increased cancer risk and require endoscopic surveillance. Eosinophilic oesophagitis is an increasingly recognised cause of food impaction in young adults, in parallel with allergic disease. Pharyngeal pouch (Zenker's diverticulum) can be dangerous โ€” regurgitation of food from the pouch during anaesthetic induction causes aspiration pneumonia. Any patient with a pharyngeal pouch must have this documented in their records and surgical pre-assessment teams must be alerted.
4
Diagnose

Targeted Examination

Weight and BMI
Weigh at every consultation โ€” weight loss quantifies severity and urgency (dysphagia alone qualifies for suspected cancer pathway referral; weight loss adds urgency). Assess nutrition using weight trend, BMI, percentage unintentional weight loss, intake, functional status and MUST where appropriate.
Oral cavity
Dental health (poor dentition contributes to dysphagia), oral candidiasis (immunocompromised, steroid inhaler use), oropharyngeal mass, tonsillar asymmetry
Neck
Lymphadenopathy (malignancy), thyroid enlargement (goitre causing extrinsic compression), neck pulsation/lump palpable on swallowing (pharyngeal pouch), tracheal deviation
Neurological
Dysarthria (stroke, MND, Parkinson's), wet/gurgling voice (aspiration), tongue wasting and fasciculations (MND โ€” bulbar onset), facial weakness, Parkinson's features (rigidity, bradykinesia, tremor)
Respiratory
Chest auscultation โ€” aspiration pneumonia crackles (basal โ€” right lower lobe most common). SpO2. Respiratory compromise from oesophageal compression (large tumour, thyroid)
Abdomen
Epigastric mass (gastric cancer), hepatomegaly (metastases from oesophageal/gastric primary), ascites (peritoneal spread)
Tongue fasciculations are a pathognomonic sign of lower motor neurone involvement and should be specifically looked for in any patient with progressive oropharyngeal dysphagia โ€” bulbar-onset MND is easily missed if the neurological examination is not complete. A wet or "gurgling" voice after swallowing indicates material pooling in the hypopharynx and is a clinical sign of aspiration risk โ€” SALT referral is immediate. Oropharyngeal candidiasis causes dysphagia (particularly painful swallowing โ€” odynophagia) and is common in patients using inhaled corticosteroids who do not rinse their mouth after use, diabetics, and immunocompromised patients.
5
Refer

Referral โ€” The Priority Step in Dysphagia

999
Suspected complete obstruction with airway compromise, respiratory distress, inability to protect the airway, severe chest pain or suspected perforation, haemodynamic instability or significant aspiration; active haematemesis, haematemesis with instability or known varices; suspected ACS or aortic emergency; suspected acute stroke (local stroke pathway)
Same-day
Suspected complete obstruction or food bolus impaction (unable to swallow saliva, drooling, persistent regurgitation) โ†’ immediate hospital transfer for urgent endoscopic management per the local upper-GI emergency pathway โ€” a patient managing secretions may not need an ambulance. Acute neurological dysphagia post-stroke โ†’ stroke pathway (999 if suspected acute stroke), NIL BY MOUTH until swallow screen. New aspiration symptoms with respiratory compromise, hypoxia, sepsis or inability to maintain hydration. Severe weight loss with inability to swallow fluids.
Suspected cancer ยท upper GI
Any unexplained dysphagia at any age (NICE NG12 (updated April 2026): suspected cancer pathway referral for oesophageal or stomach cancer), including with weight loss or iron-deficiency anaemia; age โ‰ฅ55 with weight loss plus upper abdominal pain, reflux or dyspepsia; suspected oesophageal or gastric cancer. Use the local pathway; do not delay referral while trialling a PPI.
Neurological / oropharyngeal
Route by presentation rather than only to upper GI: acute stroke pathway, SALT, neurology, ENT/head and neck cancer pathway or upper GI cancer pathway.
Suspected cancer ยท head & neck
Oropharyngeal dysphagia + neck mass, lump in throat + weight loss + hoarseness โ€” if uncertain whether upper GI or head/neck pathway, refer both
SALT (Speech and Language Therapy)
Refer patients with suspected oropharyngeal dysphagia to SALT for clinical swallowing assessment โ€” aspiration risk, diet/fluid modification, posture strategies and swallowing exercises only as SALT recommends. Urgent for stroke/MND and for aspiration symptoms (with urgent dietetic assessment). Via GP referral or community SALT.
Gastroenterology
Suspected achalasia/motility disorder (manometry arranged by gastroenterology after structural disease has been excluded; Heller myotomy / POEM), eosinophilic oesophagitis (OGD + biopsies + specialist-directed treatment; recurrent food bolus โ†’ urgent review), GORD not responding to PPI
NICE NG12 (updated April 2026) states that dysphagia at any age warrants a suspected cancer pathway referral for oesophageal or stomach cancer (recommendations 1.2.1 and 1.2.7, amended 2025, which replaced urgent direct-access upper GI endoscopy) โ€” there is no age threshold for dysphagia, so younger patients are not exempt. Submitting both a head and neck and an upper GI suspected cancer pathway referral when uncertain about the level is acceptable โ€” the specialist team will direct appropriately after flexible nasendoscopy or endoscopy. SALT involvement is critical in oropharyngeal dysphagia โ€” aspiration pneumonia is the most common cause of death in neurological dysphagia, and SALT-guided modified diet (IDDSI framework) and feeding tube decisions are specialist decisions that should not be made in primary care alone.
6
Diagnose

Investigations

Bloods
Clinically targeted, not a mandatory panel: FBC ยท Ferritin/iron studies if anaemia or suspected GI blood loss ยท U&E/renal function ยท LFTs ยท CRP if infection/inflammation suspected ยท TFTs if thyroid enlargement or relevant symptoms ยท Glucose/HbA1c where clinically indicated ยท B12/folate in neurological dysphagia or nutritional risk
Nutritional screen
Assess nutrition using weight trend, BMI, percentage unintentional weight loss, intake, functional status and MUST score where appropriate. Interpret albumin in clinical context (affected by inflammation, infection, liver and renal disease, hydration); do not use it alone to diagnose malnutrition.
Endoscopy
Upper GI endoscopy (OGD) โ€” generally the preferred diagnostic investigation for oesophageal dysphagia. Identifies malignancy, stricture, reflux oesophagitis and Barrett's; allows biopsies (consider biopsies for eosinophilic oesophagitis even if the mucosa appears normal โ€” BSG). Allows dilatation of benign strictures. Arranged via the suspected cancer pathway.
Barium swallow
Useful when Zenker's or proximal structural disease is suspected; high-risk stricture or perforation concern; endoscopy incomplete or unsuitable; achalasia or another motility disorder being evaluated; or specialist assessment requests it. Also: video fluoroscopy (VFSS) โ€” gold standard for oropharyngeal aspiration (arranged by SALT).
CXR
Not routinely required for all dysphagia. Use if aspiration pneumonia, mediastinal disease or another thoracic diagnosis is suspected (e.g. right lower lobe consolidation, mediastinal widening, absent gastric air bubble in achalasia).
NOT in primary care
CT chest/abdomen โ€” staging investigation, not diagnostic. Arranged by secondary care after endoscopic diagnosis. Oesophageal manometry (achalasia/motility) โ€” arranged by gastroenterology after structural disease has been excluded (BSG 2019).
Iron-deficiency anaemia in the context of dysphagia raises the probability of upper GI malignancy โ€” the dysphagia alone mandates a suspected cancer pathway referral (NICE NG12), and the IDA also needs its own work-up (FIT under NICE NG12 with HTG690; BSG 2021 bidirectional endoscopy). The Paterson-Kelly (Plummer-Vinson) syndrome (iron-deficiency anaemia + dysphagia + oesophageal web) is a rare but important condition that predisposes to postcricoid carcinoma โ€” iron replacement alone may resolve the web. CXR showing an absent gastric air bubble is a classical radiological sign of achalasia โ€” the fundal air shadow normally visible below the left hemidiaphragm is absent because no air can enter from the oesophagus past the tight lower oesophageal sphincter.
7
Treat

GP-Initiated Management

GORD / peptic oesophagitis
PPI (dose per suspected diagnosis and local formulary)
If reflux symptoms are prominent, a PPI may be prescribed for symptom control while urgent referral proceeds. Document that dysphagia has triggered referral. Review response and ongoing indication after the initial treatment course; do not use PPI response to exclude structural disease. Dysphagia is not uncomplicated GORD. True dysphagia is referred first, at any age: do not delay the suspected cancer pathway referral to trial a PPI (NICE NG12 (updated April 2026), recommendations 1.2.1 and 1.2.7); if a PPI is started for symptom control while the referral proceeds, tell the endoscopy service. H. pylori test-and-treat if dyspepsia component.
Oropharyngeal candidiasis
Antifungal per local guidance and current SPC
Oral/oropharyngeal candidiasis may be treated in primary care according to current local guidance: topical miconazole oral gel first line, or nystatin if miconazole is unsuitable, including patients on warfarin (NICE CKS); systemic if extensive. Suspected oesophageal candidiasis requires medical assessment and usually systemic treatment; dysphagia, odynophagia, immunosuppression or systemic illness should prompt specialist assessment. Fluconazole has important interactions, including with warfarin and QT-prolonging medicines. Address underlying immunosuppression โ€” inhaler rinse technique, diabetes control, check for HIV if recurrent.
Nutritional support
ONS on FP10 (ACBS)
If oral nutritional support is clinically indicated, involve a dietitian or follow local formulary/ACBS criteria (MUST โ‰ฅ2 does not automatically establish FP10 eligibility). Ensure the formulation is safe for the patient's swallowing status and aspiration risk. Severe dysphagia, aspiration or inability to meet requirements orally requires specialist nutritional planning. PEG placement is a specialist MDT decision, not routine.
Globus pharyngeusOnly when there is a lump sensation without objective difficulty swallowing and no alarm features (confirm food and liquids pass normally; no weight loss, pain, voice change or aspiration; neck and oropharynx examined). Then reassurance; PPI only if reflux symptoms; NHS Talking Therapies if anxiety contributes. Investigate or refer if alarm features develop.
Neurological โ€” Parkinson'sOptimise dopaminergic therapy (under neurology). SALT assessment; swallowing exercises and diet/fluid modification as SALT recommends. Review Parkinson's medication timing and swallowing function with the Parkinson's nurse/neurology team. Do not alter levodopa timing solely to treat dysphagia without specialist advice.
Pill-induced oesophagitisStop or review the suspected offending medicine (bisphosphonates, doxycycline, NSAIDs, iron, potassium chloride) where clinically appropriate and discuss an alternative formulation or treatment with the prescriber/specialist โ€” options depend on indication, renal function, fracture risk and specialist plan. Ensure tablets are taken with adequate water and while upright according to the product information. PPI for healing.

Next steps: see GORD and acid reflux ยท Stroke and TIA ยท Parkinson's disease ยท Malnutrition

Do not delay the suspected cancer pathway referral to trial a PPI: NICE NG12 (updated April 2026), recommendations 1.2.1 and 1.2.7, calls for the referral for dysphagia at any age, with no PPI trial first. If a PPI is started for symptom control while the referral proceeds, tell the endoscopy service โ€” acid suppression before gastroscopy can heal and mask mucosal lesions, and it was linked to missed upper GI cancers at the index gastroscopy (Bramble et al., Gut 2000). The clinical principle is "refer first; treat symptoms only with the endoscopy service informed" โ€” never "treat THEN refer." Bisphosphonate-induced oesophagitis (alendronate, risedronate) causes severe oesophageal ulceration if tablets are not taken correctly โ€” patients should take them with adequate water and remain upright according to the product information. Changing to an alternative formulation or treatment is a decision with the prescriber/specialist; IV bisphosphonates are not a simple substitution.
8
Lifestyle

Dietary Modification & Swallowing Safety

IDDSI texture modification International Dysphagia Diet Standardisation Initiative (IDDSI) โ€” 8 levels from regular to liquidised. Use IDDSI texture and fluid modifications only when recommended by SALT. Dietitian advises caloric adequacy at prescribed level. Monitor hydration, nutrition, medication administration and patient adherence.
Posture during eating Sit upright while eating, take small mouthfuls, eat slowly and remain upright after meals. Use compensatory posture (e.g. chin tuck), texture and fluid modifications only following SALT assessment, because the safest strategy varies by swallowing physiology and diagnosis.
GORD lifestyle Raise the head of the bed, avoid eating late in the evening before lying down, small frequent meals, weight loss, avoid alcohol/coffee/chocolate/fatty foods. Reduces reflux and protects oesophagus.
Smoking and alcohol cessation Both are independent risk factors for oesophageal squamous cancer and adenocarcinoma. Refer to stop smoking service at every consultation.
Oral hygiene Good oral hygiene reduces aspiration pneumonia risk from bacteria in the mouth. Encourage twice-daily toothbrushing, denture care and regular dental review. Use antimicrobial mouthwash only when specifically indicated (chlorhexidine is not routine โ€” adverse effects, altered taste, and no substitute for dental care or SALT assessment).
Medication review Review all medications for dysphagia risk (bisphosphonates, doxycycline, iron tablets, NSAIDs, KCl, quinidine). Consider alternative formulations with the pharmacist, ensuring they are safe for the patient's swallowing status (thin liquids may be unsafe). Crush medications only with SALT/pharmacist guidance.
Carer training For neurological dysphagia โ€” family/carer education on modified diet preparation, signs of aspiration (coughing, choking, wet voice), when to call 999. Dysphagia cafรฉs (SALT-run group sessions) available locally.
Hydration Dehydration worsens dysphagia (thickened secretions). Thickened fluids only when recommended by SALT โ€” they may reduce aspiration in selected patients but can contribute to dehydration, poor intake and reduced quality of life. Monitor urine output, skin turgor. IV fluids if hospitalised and unable to maintain oral intake.
Aspiration pneumonia is a major cause of death in patients with neurological dysphagia (stroke, MND, Parkinson's) โ€” risk is reduced with SALT-directed swallowing precautions. The IDDSI framework (2019) replaced earlier inconsistent texture terminology internationally โ€” using standardised IDDSI levels on prescriptions and referrals ensures consistent food preparation across care settings. Chin-tuck swallowing can help some patients but can worsen swallowing in others โ€” GPs should reinforce it only when SALT has recommended it for that patient.
9
Safety

Follow-Up & Safety-Netting

Referral tracking
Confirm hospital has received referral. Give clear safety-net advice and explain expected timeframes for the local pathway; if not heard within the expected time โ†’ patient phones hospital directly or GP chases. Arrange interim support for hydration, nutrition and aspiration risk. Do not wait for the cancer appointment if swallowing deteriorates or the patient cannot maintain intake.
Weight monitoring
Weigh at every consultation. Trend is more important than single value. Progressive weight loss despite treatment โ†’ escalate urgency. MUST frequency according to risk, weight trend and care setting.
PPI response
Review response and ongoing indication after the initial treatment course. Do not use PPI response to exclude structural disease; persisting dysphagia โ†’ ensure endoscopy has happened (do not re-trial PPI). Globus with reflux symptoms: reassess after the PPI course.
Post-endoscopy
Benign stricture dilatation: follow-up as the endoscopist advises; re-refer if dysphagia recurs (repeat dilatation may be needed). Barrett's surveillance interval set by endoscopist. Cancer diagnosis: CNS (Cancer Nurse Specialist) allocated โ€” GP provides ongoing primary care support.
Neurological dysphagia
SALT review frequency set by aspiration risk, weight and hydration, rate of neurological progression, respiratory function, patient and carer capacity, treatment goals and specialist MDT recommendations โ€” not a fixed monthly interval. PEG tube decision (specialist MDT) โ€” discuss early with patient when they have capacity (advance directive). Palliative care involvement in MND.
999 safety-net
Complete obstruction (cannot swallow saliva), haematemesis, choking episode with respiratory compromise, sudden severe chest pain (oesophageal perforation)
Same-day GP
Rapid deterioration in swallowing, new aspiration event (coughing/choking + fever) โ€” same-day hospital assessment if respiratory compromise, hypoxia, sepsis or inability to maintain hydration; weight loss accelerating
Active tracking of suspected cancer pathway referrals is a GP responsibility โ€” referrals can be lost to administrative errors, and patients do not always chase their own appointments. A written safety-net at time of referral (telling the patient to phone the hospital, with its number, if they have not heard within the time the local pathway gives) is best practice. PEG tube timing in MND is a critical specialist MDT decision โ€” placement is safer before respiratory function declines. This discussion requires advance care planning while the patient has capacity to participate.
Educational use only. Based on NICE NG12 (Suspected cancer: recognition and referral, updated April 2026; dysphagia recs 1.2.1 and 1.2.7, amended 2025), NICE NG128 (Stroke and TIA in over 16s โ€” swallow screening), BSG guidelines for oesophageal manometry and oesophageal reflux monitoring (Gut, 2019; doi:10.1136/gutjnl-2018-318115), current BSG/AUGIS upper-GI endoscopy quality standards, Bramble et al. (Gut 2000), IDDSI Framework (2019), RCSLT Dysphagia guidelines, current SPC/local formulary (fluconazole, PPIs, bisphosphonates), and local SALT, dietetic and upper-GI emergency pathways. Always adapt to individual patient context.